Akira Matsumori (ed.)

Cardiomyopathies and Heart Failure

Biomolecular, Infectious and Immune Mechanisms
Herausgeber: Matsumori, Akira

• Gebundenes Buch

Produktbeschreibung

"This volume comprises the most up-to-date account of existing knowledge on the subject of cardiomyopathy and heart failure. Its multidisciplinary approach covers cardiovascular medicine; biochemistry; immunology; molecular biology; virology; epidemiology; and clinical medicine.
Cardiomyopathies and Heart Failure: -Covers all major investigational and clinical aspects of the topic;
-Provides syntheses as well as reviews;
-Offers a unique multidisciplinary and international perspective;
-Includes an extensive list of references to relevant work;
-Targeted towards practicing physicians and basic researchers. "

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Developments in Cardiovascular Medicine 248
• Verlag: Springer Netherlands
• 2003
• Seitenzahl: 556
• Erscheinungstermin: 31. Juli 2003
• Englisch
• Abmessung: 235mm x 155mm x 30mm
• Gewicht: 1089g
• ISBN-13: 9781402074387
• ISBN-10: 1402074387
• Artikelnr.: 21927452

Inhaltsangabe

Contributors. Preface.
I: Introductory Chapter. Cardiomyopathies and Heart Failure: Biomolecular, Infections and Immune Mechanisms; A. Matsumori.
II: Cytokines in Cardiomyopathies and Heart Failure. 1. Chemokines and Cardiovascular Diseases; K. Matsushima, et al. 2. Negative Regulator of Cytokine Signaling (SOCS) Genes in Inflammation; I. Kinjyo, et al. 3. The Interleukin-6 Family of Cytokines and their Receptors in Patients with Congestive Heart Failure; K. Yamauchi-Takihara, et al. 4. Animal Model of Cardiomyopathy Due to Overexpression of TNF-alpha; T. Kubota.
III: Autoimmunity in Cardiomyopathies and Heart Failure. 5. Myosin Autoreactive T Cells and Autoimmune Myocarditis: Lessons from the Disease Caused by Cardiac Myosin Peptide CM2; T. Izumi, et al. 6. Autoimmunity in Cardiomyopathies; M. Noutsias, et al. 7. Anti-G-Protein Coupled Cardiac Receptor Autoantibodies in Dilated Cardiomyopathy; M. Fu. 8. Clinical Significance of Circulating Cardiac Autoantibodies in Dilated Cardiomyopathy and Myocarditis; A.L.P. Caforio, W.J. McKenna.
IV: Mast Cell Mediators and Human Diseases: Basic Aspects. 9. Development of Mast Cells: Process and Regulatory Mechanisms; Y. Kitamura, et al. 10. Mast Cells in Experimental Myocardial Infarction; N.G. Frangogiannis, M.L. Entman. 11. possible Involvement of Mast Cells in the Development of Fibrosis; M. Kurosawa, et al. 12. Human Mast Cell Chymase and 31 Amino Acid Endothelin-1; H. Kido, et al. 13. Tryptase from Human mast Cells; L.B. Schwartz. 14.